182 related articles for article (PubMed ID: 23551961)
1. FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Smith JW; Horsewood P; Moore JC; Warkentin TE; Crowther MA; Kelton JG
J Thromb Haemost; 2013 Jun; 11(6):1146-53. PubMed ID: 23551961
[TBL] [Abstract][Full Text] [Related]
2. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
[TBL] [Abstract][Full Text] [Related]
3. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis of heparin-induced thrombocytopenia.
Warkentin TE
Int J Lab Hematol; 2019 May; 41 Suppl 1():15-25. PubMed ID: 31069988
[TBL] [Abstract][Full Text] [Related]
5. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.
Warkentin TE; Sheppard JI; Moore JC; Sigouin CS; Kelton JG
J Thromb Haemost; 2008 Aug; 6(8):1304-12. PubMed ID: 18489711
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
7. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-release assay-negative heparin-induced thrombocytopenia.
Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
[TBL] [Abstract][Full Text] [Related]
10. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
[TBL] [Abstract][Full Text] [Related]
11. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.
Bachelot-Loza C; Saffroy R; Lasne D; Chatellier G; Aiach M; Rendu F
Thromb Haemost; 1998 Mar; 79(3):523-8. PubMed ID: 9531034
[TBL] [Abstract][Full Text] [Related]
12. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
13. Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT).
Warkentin TE; Sheppard JI; Smith JW; Li N; Moore JC; Arnold DM; Nazy I
J Thromb Haemost; 2020 Jun; 18(6):1435-1446. PubMed ID: 32167669
[TBL] [Abstract][Full Text] [Related]
14. Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia.
Lee CSM; Selvadurai MV; Pasalic L; Yeung J; Konda M; Kershaw GW; Favaloro EJ; Chen VM
J Thromb Haemost; 2022 Apr; 20(4):975-988. PubMed ID: 35038779
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests.
Greinacher A; Ittermann T; Bagemühl J; Althaus K; Fürll B; Selleng S; Lubenow N; Schellong S; Sheppard JI; Warkentin TE
J Thromb Haemost; 2010 Sep; 8(9):2025-31. PubMed ID: 20626620
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia.
Rubino JG; Arnold DM; Warkentin TE; Smith JW; Kelton JG; Nazy I
J Thromb Haemost; 2021 Apr; 19(4):1096-1102. PubMed ID: 33387395
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory.
Nazi I; Arnold DM; Moore JC; Smith JW; Ivetic N; Horsewood P; Warkentin TE; Kelton JG
Am J Hematol; 2015 Jul; 90(7):629-33. PubMed ID: 25809312
[TBL] [Abstract][Full Text] [Related]
18. Laboratory testing for VITT antibodies.
Warkentin TE; Greinacher A
Semin Hematol; 2022 Apr; 59(2):80-88. PubMed ID: 35512905
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL
Warkentin TE; Sheppard JI; Linkins LA; Arnold DM; Nazy I
Thromb Res; 2017 May; 153():108-117. PubMed ID: 28391124
[TBL] [Abstract][Full Text] [Related]
20. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
